Effects of THC/CBD oromucosal spray on spasticity-related symptoms in people with multiple sclerosis: results from a retrospective multicenter study
Mario Zappia(University of Catania), Simona Pontecorvo(Sapienza University of Rome), Eliana Berra(Agostino Gemelli University Polyclinic), Daniele Spitaleri(Azienda Ospedaliera S.Giuseppe Moscati), Eleonora Tavazzi(Magna Graecia University), Letizia Castelli(Multiple Sclerosis Foundation), Claudio Gasperini(Nini Hospital), Elisabetta Signoriello(ATS Sardegna (Italy)), Francesco Saccà(Federico II University Hospital), Loredana Petrucci(University of Pisa), Giovanna Salamone(University of Campania "Luigi Vanvitelli"), Isabella Righini, Domenico Ippolito(University of Campania "Luigi Vanvitelli"), Roberta Lanzillo(University of Naples Federico II), Gianfranco Costantino(Ospedali Riuniti di Foggia), Raffaella Cerqua(University of Foggia), Clara Grazia Chisari(University of Catania), Roberto Bruno Bossio(Azienda Ospedaliera di Cosenza), Maria Donata Benedetti(University of Verona), Damiano Paolicelli(University of Bari Aldo Moro), Paola Cavalla, Francesco Patti(University of Catania), Margherita Russo(University of Campania "Luigi Vanvitelli"), Maria Paola Trotta(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Manuela Matta(Ospedale San Luigi Gonzaga), Gabriella Spinicci(University of Cagliari), Assunta Bianco(Università Cattolica del Sacro Cuore), Fabio Buttari(Istituto Neurologico Mediterraneo), Claudio Solaro(Rina Services (Italy)), Giorgia Teresa Maniscalco(Ospedale Antonio Cardarelli), Mauro Zaffaroni(Associazione Italiana Sclerosi Multipla), Angelica Guareschi(University of Campania "Luigi Vanvitelli")
Cited by 26
Related Papers
Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A
|Nature Genetics|2004|1.6k
MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines
|The Lancet Neurology|2016|863
2021 MAGNIMS–CMSC–NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis
|The Lancet Neurology|2021|646